Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at ...

Late-breaking research finds no survival benefit from autologous stem cell transplant in mantle cell lymphoma patients with ...

The Global Autologous Cell Therapy Market has seen significant growth and is expected to continue expanding with a projected CAGR of 18.1% from 2019 to 2027, reaching a market value of approximately ...

Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...

This important study describes a first-in-human trial of autologous p63+ stem cells in patients with idiopathic pulmonary fibrosis, a lethal condition for which effective treatments are lacking. The ...

Autologous stem cell transplant plus Rituxan did not improve survival outcomes in certain patients with mantle cell lymphoma compared with Rituxan alone.

Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101: Philadelphia Monday, December 23, 2024, 13:00 Hrs [IST] Vittoria Biotherapeutics, Inc, a clini ...

To address these problems, we propose an autologous variable stiffness soft finger (AVSSF) that integrates the cross-layer jamming joints (CLJJs) as both the variable stiffness unit and the finger ...

A lack of these epitheliotrophic factors—for example, in dry eye, can result in severe ocular surface disorders such as persistent epithelial defects. Recently, the use of autologous serum in the form ...

However, procurement of large flaps can cause significant defects, complicating wound closure and increasing postoperative risks. This study details the surgical techniques and outcomes of autologous ...